Scott M. Rocklage, Director, 10% Owner at EPIRUS Biopharmaceuticals, Inc. (EPRS), bought 400,000 shares at $5.00 ($2.0M) on 2015-02-04, disclosed to the SEC on 2015-02-06.
Open-market purchase of $2.0M EPRS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 10,050 | $50K | 2.5% |
| 2 | $5.00 | 389,950 | $1.9M | 97.5% |
| Total | $5.00 avg | 400,000 | $2.0M | 100% |
| Filing → |
| APRE | SELL | 2020-06-18 | $8.0M | — | Filing → |
| APRE | SELL | 2020-06-15 | $7.0M | — | Filing → |
| APRE | SELL | 2020-05-21 | $9.0M | — | Filing → |